Supporting patients to get the best from their osteoporosis treatment: a rapid realist review of what works, for whom, and in what circumstance Z. PaskinsO. Babatundeon behalf of the Effectiveness Working Group of the Royal Osteoporosis Society Osteoporosis, Bone Research Academy Review Open access 11 June 2022 Pages: 2245 - 2257
Management of osteoporosis in patients with chronic kidney disease M. AbdalbaryM. SobhA. El-Husseini Review 24 June 2022 Pages: 2259 - 2274
Relationship between prevalence and risk of osteoporosis or osteoporotic fracture with non-alcoholic fatty liver disease: A systematic review and meta-analysis Binjing PanJing CaiQiong Li Review 28 June 2022 Pages: 2275 - 2286
Effect of institution volume on mortality and outcomes in osteoporotic hip fracture care Farzad ShabaniGeorgios TsinaslanidisNicholas Alan Johnson Original Article 08 January 2022 Pages: 2287 - 2292
Correction to: Effect of institution volume on mortality and outcomes in osteoporotic hip fracture care Farzad ShabaniGeorgios TsinaslanidisNicholas Alan Johnson Correction 03 May 2022 Pages: 2293 - 2293
Correction to: Effect of institution volume on mortality and outcomes in osteoporotic hip fracture care Farzad ShabaniGeorgios TsinaslanidisNicholas Alan Johnson Correction 23 September 2022 Pages: 2295 - 2295
Menopausal hormone therapy reduces the risk of fracture regardless of falls risk or baseline FRAX probability—results from the Women’s Health Initiative hormone therapy trials Mattias LorentzonHelena JohanssonJohn A. Kanis Original Article Open access 14 July 2022 Pages: 2297 - 2305
Distal radius fractures and risk of incident neurocognitive disorders in older adults: a retrospective cohort study Joshua M. BaruthMaria I. LapidJörgen Åstrand Original Article 15 July 2022 Pages: 2307 - 2314
Characteristics of fallers who later sustain a hip fracture: a NOREPOS study Anne Johanne SøgaardRuth AgaHaakon E. Meyer Original Article Open access 04 August 2022 Pages: 2315 - 2326
Hospitalizations for major osteoporotic fractures in Switzerland: a long-term trend analysis between 1998 and 2018 Kurt LippunerGergana RimmerOliver Bock Original Article Open access 02 August 2022 Pages: 2327 - 2335
The economic burden of osteoporosis in Iran in 2020 Afshin OstovarAbdoreza MousaviRajabali Daroudi Original Article 11 July 2022 Pages: 2337 - 2346
Socioeconomic status influences on bone mineral density in American men: findings from NHANES 2011–2020 Pei-Lun XiaoCairen FuerwaHua-Ding Lu Original Article 14 July 2022 Pages: 2347 - 2355
Long-term exposure to air pollution might decrease bone mineral density T-score and increase the prevalence of osteoporosis in Hubei province: evidence from China Osteoporosis Prevalence Study Faxue ZhangFang ZhouWei Zhu Original Article 13 July 2022 Pages: 2357 - 2368
Is repeated childhood fracture related to areal bone density or body composition in middle age? Meredith-Jones KimHaszard JillianPoulton Richie Original Article Open access 02 August 2022 Pages: 2369 - 2379
Predicting the acute-phase response fever risk in bisphosphonate-naive osteoporotic patients receiving their first dose of zoledronate Ke LuQin ShiChong Li Original Article 03 August 2022 Pages: 2381 - 2396
Sickle cell bone disease and response to intravenous bisphosphonates in children C. GrimblyP. Diaz EscagedoL. M. Ward Original Article Open access 29 July 2022 Pages: 2397 - 2408
Comparison of the efficacy between sequential therapy with teriparatide and denosumab and denosumab monotherapy in suppressing fragility fracture risk Jae-Won ShinQuen HeHak-Sun Kim Original Article 04 August 2022 Pages: 2409 - 2416
Renal safety of zoledronic acid for osteoporosis in adults 75 years and older Cy W. FixenDanielle R. Fixen Original Article 13 July 2022 Pages: 2417 - 2422
Anabolic actions of parathyroid hormone in a hypophosphatasia mouse model Amy J KohHwa Kyung NamNan E Hatch Original Article Open access 23 July 2022 Pages: 2423 - 2433
Patients not taking a previously prescribed bone active medication now prescribed medication through Ontario FLS J. E. M. SaleA. YangE. Bogoch Short Communication 28 June 2022 Pages: 2435 - 2440
Impact of the duration of previous osteoporosis treatment on the effect of romosozumab in patients with postmenopausal osteoporosis Kosuke EbinaYuki EtaniKen Nakata Letter to the Editor 06 September 2022 Pages: 2441 - 2443
An LRP6 mutation (Arg360His) associated with low bone mineral density but not cardiovascular events in a Caucasian family Nuria PuenteAna I. VegaJose A. Riancho Case Report Open access 15 July 2022 Pages: 2445 - 2448
Regression of calcinosis cutis after inkless tattoo in a patient with dermatomyositis: therapeutic potential of microneedling Yasaman MotlaghzadehLaila S. TabatabaiDeborah E. Sellmeyer Case Report 26 July 2022 Pages: 2449 - 2452
